RA Capital Management, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), sold 2,711,352 shares at $11.78 ($30.7M) on 2014-08-26, disclosed to the SEC on 2014-08-27.
Open-market sale of $30.7M ACHN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.94 | 226,200 | $2.5M | 8.1% |
| 2 | $11.01 | 105,196 | $1.2M | 3.8% |
| 3 | $11.13 | 1,347,639 | $15.0M | 48.8% |
| 4 | $11.16 | 52,361 | $584K | 1.9% |
| 5 | $11.77 | 312,867 | $3.7M | 12.0% |
| 6 | $11.78 | 150,000 |
| $1.8M |
| 5.8% |
| 7 | $11.80 | 250,000 | $3.0M | 9.6% |
| 8 | $11.48 | 150,100 | $1.7M | 5.6% |
| 9 | $11.75 | 116,989 | $1.4M | 4.5% |
| Total | $11.33 avg | 2,711,352 | $30.7M | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |